Tradestie Institutional Equity Comparison Engine

PACS vs ENSG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENSG Overall Edge

ENSG Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to The Ensign Group, Inc. (ENSG) driven by superior Growth & Margin, Options & Structure while PACS counters with relative strength in Valuation, Momentum & Technical. Fundamentally, PACS trades at 15.3x Forward P/E with 7.4% operating margin (+11.5% YoY revenue) versus ENSG at 20.1x Forward P/E and 8.8% operating margin (+14.5% YoY). In options structure, PACS sits in CONSOLIDATION (11th %ile IV; Dealer Gamma Walls on Pro) against ENSG sits in CONSOLIDATION (62nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PACS
PACS 15.3x vs ENSG 20.1x Fwd P/E
Growth & Margin Winner ENSG
Op Margin 7.4% vs 8.8% ยท YoY +11.5% vs +14.5%
Momentum & Technical Winner PACS
1Y +159.5% vs -1.3% ยท 52W Pos 79% vs 46%
Options & Structure Winner ENSG
CONSOLIDATION (11th %ile IV) vs CONSOLIDATION (62nd %ile IV)
PACS NYSE
PACS Group, Inc.
Services-Skilled Nursing Care Facilities
$43.67
+1.49% 1D
Market Cap $6.8B
1M Return -8.06%
1Y Return +159.48%
Forward P/E 15.3x
Unified AI Score
46.8 / 100 HOLD
Tech 35.0 Fund 48.0 Flow 62.0 Mom 50.0
ENSG NASDAQ
The Ensign Group, Inc.
Services-Skilled Nursing Care Facilities
$176.32
-0.15% 1D
Market Cap $10.3B
1M Return -1.14%
1Y Return -1.34%
Forward P/E 20.1x
Unified AI Score
48.3 / 100 HOLD
Tech 45.0 Fund 54.0 Flow 67.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PACS +159.48% ENSG -1.34% Spread: +160.82 pp (PACS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PACS Revenue ENSG Revenue PACS Op. Margin ENSG Op. Margin Margin Edge
FY2018 N/A $1.75B N/A 4.8% ENSG
FY2019 N/A $2.04B N/A 6.3% ENSG
FY2020 N/A $2.39B N/A 9.3% ENSG
FY2021 N/A $2.63B N/A 9.9% ENSG
FY2022 $2.40B $3.03B 9.6% 9.8% ENSG
FY2023 $3.11B $3.71B 6.7% 6.9% ENSG
FY2024 $4.09B $4.24B 3.0% 8.5% ENSG
FY2025 $5.29B $5.03B 5.9% 8.5% ENSG

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PACS (3) vs ENSG (6)
Institutional Metric PACS ENSG Criterion Row Winner
Market Capitalization Scale $6.8B $10.3B Larger Scale ENSG
Trailing P/E Ratio Valuation 26.2x 26.3x Lower Multiple Tie
Forward P/E Ratio Valuation 15.3x 20.1x Lower Multiple PACS
Revenue Growth (YoY) Growth +11.5% +14.5% Higher Growth ENSG
Operating Margin (TTM) Profitability 7.4% 8.8% Higher Margin ENSG
Net Profit Margin Profitability 4.9% 7.0% Higher Margin ENSG
Return on Equity (ROE) Capital Efficiency 26.5% 17.1% Higher ROE PACS
52-Week Range Position Momentum 79% ($14โ€“$52) 46% ($142โ€“$218) Stronger Trend PACS
Beta / 30D Volatility Risk Regime 0.78ฮฒ ยท 51% Vol 0.12ฮฒ ยท 42% Vol Lower Realized Risk ENSG
Unified Institutional Score Composite Signal 46.8 / 100 (HOLD) 48.3 / 100 (HOLD) Higher Composite ENSG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PACS vs ENSG Buy Guide
PACS CONSOLIDATION
83d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live PACS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ENSG CONSOLIDATION
73d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 62nd %ile
IV Regime Elevated (60thโ€“80th %ile)
Live ENSG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PACS nor ENSG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.